Clinicopathological Profile, Histopathological Spectrum, Prevalence, and Factors Associated with Malignancy in Solitary Thyroid Nodules
DOI:
https://doi.org/10.51985/Keywords:
Solitary Thyroid Nodule; Thyroid Malignancy; Papillary Carcinoma; Bethesda SystemAbstract
Objective: To determine the frequency and histopathological spectrum of malignancy among surgically treated solitary thyroid nodules (STNs) and assess associated clinical, sonographic, and cytological features.
Study Design & Setting: Descriptive cross-sectional study. Department of General Surgery, Surgical Ward 2, Jinnah Postgraduate Medical Centre (JPMC), Karachi, from 25 August 2025 to 25 February 2026.
Methodology: Fifty-eight consecutive patients aged 16–70 years with STNs who underwent thyroid surgery were included. Clinical and ultrasonographic findings, preoperative Bethesda cytology, and final histopathology were recorded. Categorical variables were analysed using Fisher's exact or Fisher-Freeman-Halton exact tests, as appropriate. A p-value < 0.05 was considered significant. Data were analysed using SPSS version 26.
Results: Of 58 patients, 45 (77.6%) were female and 13 (22.4%) were male; mean age was 43.24 ± 16.46 years. Malignancy was found in 22 (37.9%) patients. Papillary carcinoma was most common (72.7%), followed by follicular (18.2%), medullary (4.5%), and poorly differentiated carcinoma (4.5%). Female sex was associated with malignancy (p = 0.001); microcalcifications, irregular margins, and Bethesda category were also associated (all p < 0.001). Malignancy occurred in 6/17 (35.3%) Bethesda IV nodules and all Bethesda V and VI nodules.
Conclusion: Malignancy was found in 22/58 (37.9%) surgically treated STNs. Microcalcifications, irregular margins, and higher Bethesda categories were strongly associated with malignant histopathology. Female sex was an observed association and should be interpreted cautiously.
Downloads
References
1. Durante C, Hegedüs L, Czarniecka A, Paschke R, Russ G,
Schmid KW, et al. 2023 European Thyroid Association Clinical
Practice Guidelines for thyroid nodule management. Eur
Thyroid J. 2023;12(5):e230067. doi: 10.1530/ETJ-23-0067.
2. Burman KD, Wartofsky L. Thyroid nodules. N Engl J Med.
2015;373(24):2347-56. Updated review: Hegedüs L, Bonnema
SJ, Ellervik C. Evaluation of thyroid nodules: a clinical update.
Lancet Diabetes Endocrinol. 2023;11(11):800-12.
3. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R,
Leenhardt L. European Thyroid Association guidelines for
ultrasound malignancy risk stratification of thyroid nodules
in adults: 2024 update of EU-TIRADS. Eur Thyroid J.
2024;13(2):e230237.
4. Khan A, Naveed K, Khalid M, Saeed A. Prevalence of
malignancy in solitary versus multinodular thyroid lesions:
a comparative analysis. Pak J Med Sci. 2022;38(6):1583-8.
5. Ahmed I, Hussain A, Rasool S, Ali S, Khan F. Comparative
analysis of malignancy risk in solitary and multinodular
thyroid swellings. J Coll Physicians Surg Pak. 2023;33(8):870-
4.
6. Tessler FN, Middleton WD, Grant EG. Thyroid Imaging
Reporting and Data System (TI-RADS): a user’s guide.
Radiology. 2021;299(1):31-43. doi: 10.1148/radiol. 2021202
716.
7. Castellana M, Castellana C, Treglia G, Giorgino F, Giovanella
L, Russ G, et al. Performance of five ultrasound riskstratification systems in selecting thyroid nodules for FNA:
an updated systematic review and meta-analysis. J Clin
Endocrinol Metab. 2022;107(5):e1842-55.
8. Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh
P, VanderLaan PA. The 2023 Bethesda System for Reporting
Thyroid Cytopathology. Thyroid. 2023;33(9):1039-44. doi:
10.1089/thy.2023.0141
9. Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W,
et al. The American Association of Endocrine Surgeons
guidelines for the definitive surgical management of thyroid
disease in adults. Ann Surg. 2022;275(3):e519-50.
10. Iqbal M, Mehmood Z, Rasul S, Inam-Pal H, Ashraf MN,
Khan MA. Spectrum of malignancy in solitary thyroid nodules
at a tertiary care hospital. Pak J Med Health Sci.
2021;15(11):3265-7.
11. Riaz A, Khan AR, Iqbal F, Akhtar W. Frequency and pattern
of thyroid malignancy in solitary thyroid nodules in a tertiary
care hospital of Pakistan. J Pak Med Assoc. 2022;72(9):1748-
52.
12. Aslam M, Khan SA, Aslam H, Idrees R. Histopathological
pattern of solitary thyroid nodules in a tertiary care hospital
of Karachi. J Coll Physicians Surg Pak. 2021;31(5):613-5.
13. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli
P, Doherty GM, et al. American Thyroid Association guidelines
on the management of thyroid nodules and differentiated
thyroid cancer task force review and recommendation on the
proposed renaming of encapsulated follicular variant papillary
thyroid carcinoma without invasion to noninvasive follicular
thyroid neoplasm with papillary-like nuclear features. Thyroid.
2022;32(7):742-58.
14. Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD,
Newbold K, et al. ESMO Clinical Practice Guideline update
on the use of systemic therapy in advanced thyroid cancer.
Ann Oncol. 2022;33(7):674-84.
15. Ahmed A, Saeed S, Khan I, Iqbal M, Yasmeen S, Khan TA.
Frequency of malignancy in patients undergoing thyroidectomy
for solitary thyroid nodule: a single-centre study. Cureus.
2022;14(8):e28301. doi: 10.7759/cureus.28301.
16. Ali R, Irfan T, Shafqatullah S, Iqbal M, Fareed A, Zafar K.
Diagnostic accuracy of fine needle aspiration cytology in
solitary thyroid nodule. Int J Health Rehab Res. 2025;3(3):213-
9.
17. Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A,
Verma AK, et al. Pattern and predictors of malignancy in
solitary thyroid nodules in iodine-replete northern India: a
prospective cohort. Indian J Surg. 2022;84(3):553-9.
18. Kalra S, Singh V, Kumar A, Sharma A, Mahajan R. Risk of
malignancy in solitary thyroid nodules: a single-centre
experience from a tertiary referral hospital in India. World J
Endocr Surg. 2023;15(1):17-21.
19. Sharma R, Bhatt M, Kumar P, Gupta S. Clinico-pathological
evaluation of solitary thyroid nodules: a prospective study
from a tertiary care hospital. Indian J Otolaryngol Head Neck
Surg. 2024;76(2):1502-8.
20. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends
in thyroid cancer incidence and mortality in the United States,
2000–2019. JAMA. 2022;327(11):1075-7.
21. Cabanillas ME, Ryder M, Jimenez C. Targeted therapy for
advanced thyroid cancer: kinase inhibitors and beyond. Endocr
Rev. 2022;43(5):873-902.
22. La Vecchia C, Negri E. The thyroid cancer epidemic —
overdiagnosis or a real increase? Nat Rev Endocrinol.
2023;19(8):440-1.
23. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia
C, et al. The epidemiological landscape of thyroid cancer
worldwide: GLOBOCAN estimates for incidence and mortality
rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264-
72.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0
